Helen Heng-Shan Moon, MD, hematologist/oncologist, Kaiser Permanente Riverside Medical Center, discusses the current state of the prostate cancer paradigm as well as unmet needs in the space.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.